Intervention Review

Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease

  1. Richard W Orrell1,*,
  2. Russell JM Lane2,
  3. Mark Ross3

Editorial Group: Cochrane Neuromuscular Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 21 JUN 2010

DOI: 10.1002/14651858.CD002829.pub4


How to Cite

Orrell RW, Lane RJM, Ross M. Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002829. DOI: 10.1002/14651858.CD002829.pub4.

Author Information

  1. 1

    University College London Institute of Neurology, Department of Clinical Neurosciences, London, UK

  2. 2

    Imperial College NHS Trust, West London Neurosciences Centre, London, UK

  3. 3

    Mayo Clinic Scottsdale, Department of Neurology, Scottsdale, Arizona, USA

*Richard W Orrell, Department of Clinical Neurosciences, University College London Institute of Neurology, Royal Free Campus, Rowland Hill Street, London, NW2 3PF, UK. r.orrell@ucl.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 24 JAN 2007

SEARCH